Monte Carlo simulation of irradiation and killing in three-dimensional cell populations with lognormal cellular uptake of radioactivity

International Journal of Radiation Biology

Volumn 88, Issue 1-2, 2012, Pages 115-122

  Howell, Roger W ^a   Rajon, Didier ^b   Bolch, Wesley E ^c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c University of Florida   (United States)

Author keywords

Electron; Multicellular dosimetry; Polonium 210; Radionuclide

Indexed keywords

POLONIUM;

ALPHA RADIATION; ANIMAL CELL; CELL CULTURE; CELL DEATH; CELL NUCLEUS; CELL POPULATION; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; HUMAN; HUMAN CELL; IRRADIATION; LOW ENERGY RADIATION; MONTE CARLO METHOD; NONHUMAN; POSITRON; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOACTIVITY; THREE DIMENSIONAL IMAGING;

ANIMALS; CELL DEATH; CELL LINE; CELL SURVIVAL; CRICETINAE; CRICETULUS; IMAGING, THREE-DIMENSIONAL; MONTE CARLO METHOD; RADIOBIOLOGY; RADIOMETRY; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 84855401279     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2011.602379     Document Type: Conference Paper

References (62)

1. Akudugu JM, Neti PVSV, Howell RW. 2011. Changes in lognormal shape parameter guide design of patient-specifc radiochemother-apy cocktails. Journal of Nuclear Medicine 52:642-649.
2. 212Pb localized in the nucleus of mammalian cells: Role of recoil energy in the radiotoxicity of internal alpha emitters. Radiation Research 140:276-283. (Pubitemid 24347109)
3. Bishayee A, Hill HZ, Stein D, Rao DV, Howell RW. 2001. Free-radical initiated and gap junction-mediated bystander efect due to non-uniform distribution of incorporated radioactivity in a three-dimensional tissue culture model. Radiation Research 155:335-344. (Pubitemid 32125985)
4. Bolch WE, Bouchet LG, Robertson JS, Wessels BW, Siegel JA, Howell RW, Erdi AK, Aydogan B, Costes S, Watson EE. 1999. MIRD Pamphlet No. 17: Te dosimetry of nonuniform activity distributions-radionuclide S values at the voxel level. Journal of Nuclear Medicine 40:11S-36S. (Pubitemid 29044199)
5. Bouchet LG, Bolch WE, Weber DA, Atkins HL, Poston JW Sr. 1999. MIRD Pamphlet No. 15: Radionuclide S values in a revised model of the adult head and brain. Journal of Nuclear Medicine 40:62S-101S. (Pubitemid 29120130)
6. Bouchet LG, Bolch WE, Blanco HP, Wessels BW, Siegel JA, Rajon DA, Clairand I, Sgouros G. 2003. MIRD Pamphlet No 19: Absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney. Journal of Nuclear Medicine 44:1113-1147. (Pubitemid 40003745)
7. 2 particles in the Chinese hamster. Radiation Research 96:135-151. (Pubitemid 14227819)
8. Brownell GL, Ellet WH, Reddy AR. 1968. Absorbed fractions for photon dosimetry. MIRD Pamphlet No. 3. Journal of Nuclear Medicine 9(suppl. 1):27-39.
9. 111In using Monte Carlo N-particle computer code: Comparison with analytic methods and correlation with in vitro cytotoxicity. Journal of Nuclear Medicine 51:462-470.
10. Charlton DE. 2000. Radiation efects in spheroids of cells exposed to alpha emitters. International Journal of Radiation Biology 76:1555-1564.
11. Conway JH, Sloane NJA. 1999. Sphere packings, lattices, and groups. 3rd ed. New York: Springer. 703 p.
12. 106Ru contaminated wound. Radiation Protection Dosimetry 105:219-223. (Pubitemid 37161223)
13. Ellett WH, Callahan AB, Brownell GL. 1964. Gamma-ray dosimetry of internal emitters. I. Monte Carlo calculations of absorbed dose from point sources. British Journal of Radiology 37:45-52.
14. Ellett WH, Callahan AB, Brownell GL. 1965. Gamma-ray dosimetry of internal emitters. II. Monte Carlo calculations of absorbed dose from uniform sources. British Journal of Radiology 38:541-544.
15. Feinendegen LE, Bond VP, Booz J. 1994. Te quantifcation of physical events within tissue at low levels of exposure to ionizing radiation. ICRU News (December): 9-12.
16. Goddu SM, Rao DV, Howell RW. 1994. Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. Journal of Nuclear Medicine 35:521-530. (Pubitemid 24079989)
17. Goddu SM, Howell RW, Bouchet LG, Bolch WE, Rao DV. 1997. MIRD Cellular S values: Self-absorbed dose per unit cumulated activity for selected radionuclides and monoenergetic electron and alpha particle emitters incorporated into diferent cell compartments. Reston, VA: Society of Nuclear Medicine. 183 p.
18. 131I SPECT quantifcation, registration and patient-specifc dosimetry. Cancer Biotherapy and Radiopharma-ceuticals 18:61-69. (Pubitemid 36307467)
19. 125I. Micron 33:127-132. (Pubitemid 32997012)
20. Howell RW, Neti PV. 2005. Modeling multicellular response to nonuni-form distributions of radioactivity: Diferences in cellular response to self-dose and cross-dose. Radiation Research 163:216-221. (Pubitemid 40170772)
21. Howell RW, Goddu SM, Rao DV. 1994. Application of the linear-quadratic model to radioimmunotherapy: Further support for the advantage of longer-lived radionuclides. Journal of Nuclear Medicine 35:1861-1869. (Pubitemid 24346813)
22. Howell RW, Narra VR, Rao DV, Sastry KSR. 1990. Radiobiological efects of intracellular polonium-210 alpha emissions: A comparison with Auger-emitters. Radiation Protection Dosimetry 31:325-328. (Pubitemid 20286754)
23. Howell RW, Neti P V, Pinto M, Gerashchenko BI, Narra VR, Azzam EI. 2006. Challenges and progress in predicting biological responses to incorporated radioactivity. Radiation Protection Dosimetry 122: 521-527. (Pubitemid 47090518)
24. Humm JL, Cobb LM. 1990. Nonuniformity of tumor dose in radioim-munotherapy. Journal of Nuclear Medicine 31:75-83.
25. Humm JL, Macklis RM, Bump K, Cobb LM, Chin LM. 1993. Internal dosimetry using data derived from autoradiographs. Journal of Nuclear Medicine 34:1811-1817. (Pubitemid 23295398)
26. International Commission on Radiation Units and Measurements (ICRU). 1989. Tissue substitutes in radiation dosimetry and measurement. Bethesda, MD: ICRU. Report 44.
27. International Commission on Radiation Units and Measurements (ICRU). 1993. Stopping powers and ranges for protons and alpha particles. Bethesda, MD: ICRU. Report 49.
28. Jönsson B-A, Strand S-E, Larsson BS. 1992. A quantitative autoradio-graphic study of the heterogeneous activity distribution of diferent indium-111-labeled radiopharmaceuticals in rat tissues. Journal of Nuclear Medicine 33:1825-1832.
29. Kalogianni E, Flux GD, Malaroda A. 2007. Te use of BED and EUD concepts in heterogeneous radioactivity distributions on a multicel-lular scale for targeted radionuclide therapy. Cancer Biotherapy and Radiopharmceuticals 22:143-150. (Pubitemid 46697377)
30. Kawrakow I. 2000. Accurate condensed history monte carlo simulation of electron transport. i. egsnrc, the new egs4 version. Medical Physics 27:485-498. (Pubitemid 30171797)
31. Kvinnsland Y, Stokke T, Aurlien E. 2001. Radioimmunotherapy with alpha-particle emitters: microdosimetry of cells with a heterogeneous antigen expression and with various diameters of cells and nuclei. Radiation Research 155:288-296. (Pubitemid 32125979)
32. 90Y therapy using Monte Carlo simulations. Cancer Biotherapy and Radiopharmaceuticals 18:99-107. (Pubitemid 36307471)
33. Loevinger R, Berman M. 1968. A schema for absorbed-dose calculations for biologically-distributed radionuclides. MIRD Pamphlet No. 1. Journal of Nuclear Medicine 9(Suppl. 1):7-14.
34. Makrigiorgos GM, Adelstein SJ, Kassis AI. 1990a. Cellular radiation dosimetry and its implications for estimation of radiation risks. Illustrative results with technetium-99m-labeled microspheres and macroaggregates. Journal of the American Medical Association 264:592-595. (Pubitemid 20241440)
35. Makrigiorgos GM, Ito S, Baranowska-Kortylewicz J, Vinter DW, Iqbal A, Van den Abbeele AD, Adelstein SJ, Kassis AI. 1990b. Inhomogeneous deposition of radiopharmaceuticals at the cellular level: Experimental evidence and dosimetric implications. Journal of Nuclear Medicine 31:1358-1363. (Pubitemid 20245933)
36. Malaroda A, Flux G, Ott R. 2005. Te application of dose-rate volume histograms and survival fractions to multicellular dosimetry. Cancer Biotherapy and Radiopharmaceuticals 20:58-65. (Pubitemid 40478523)
37. Malaroda A, Flux GD, Bufa FM, Ott RJ. 2003. Multicellular dosimetry in voxel geometry for targeted radionuclide therapy. Cancer Bio-therapy and Radiopharmaceuticals 18:451-461. (Pubitemid 36917888)
38. McKay E. 2003. A software tool for specifying voxel models for dosim-etry estimation. Cancer Biotherapy and Radiopharmaceuticals 18:379-392. (Pubitemid 36917880)
39. National Council on Radiation Protection and Measurements (NCRP). 1979. Tritium and other radionuclide labelled organic compounds incorporated in genetic material. Bethesda, MD: NCRP. Report 63.
40. 131I be considered uniform? An experimental basis for multicellular dosimetry. Journal of Nuclear Medicine 44:2019-2026.
41. 131I on labeled and unlabeled cells. Journal of Nuclear Medicine 45:1050-1058. (Pubitemid 47611692)
42. Neti PV, Howell RW. 2006. Log normal distribution of cellular uptake of radioactivity: implications for biologic responses to radiopharma-ceuticals. Journal of Nuclear Medicine 47:1049-1058. (Pubitemid 46939959)
43. Neti PV, Howell RW. 2008. Lognormal distribution of cellular uptake of radioactivity: statistical analysis of alpha-particle track autoradiog-raphy. Journal of Nuclear Medicine 49:1009-1016. (Pubitemid 351793443)
44. 210Po in multicellular clusters. Radiation Research 168:332-340. (Pubitemid 351295136)
45. Nettleton JS, Lawson R. 1996. Cellular dosimetry of diagnostic radio-nuclides for spherical and ellipsoidal geometry. Physics in Medicine and Biology 41:1845-1854. (Pubitemid 26288530)
46. O'Donoghue JA. 1990. Isoefect relationships for fractionated biologically targeted radiotherapy. Radiotherapy and Oncology 19:257-265. (Pubitemid 20369219)
47. O'Donoghue JA, Wheldon TE. 1989. Dose-rate efects in biologically targeted radiotherapy. International Journal of Radiation Biology 56:745-749. (Pubitemid 20002023)
48. Oakberg EF. 1971. Spermatogonial stem-cell renewal in the mouse. Te Anatomical Record 169:515-532.
49. Pinto M, Howell RW. 2007. Concomitant quantifcation of targeted drug delivery and biological response in individual cells. Biotech-niques 43(64):66-71.
50. Pinto M, Azzam EI, Howell RW. 2006. Bystander responses in three-dimensional cultures containing radiolabeled and unlabeled human cells. Radiation Protection Dosimetry 122:252-255. (Pubitemid 47090459)
51. Pinto M, Azzam EI, Howell RW. 2010. Investigation of adaptive responses in bystander cells in 3D cultures containing tritium-labeled and unla-beled normal human fbroblasts. Radiation Research 174:216-227.
52. Rajon D, Bolch WE, Howell RW. 2011. Lognormal distribution of cellular uptake of radioactivity: Monte-Carlo simulation of irradiation and cell killing in 3-dimensional populations in carbon scafolds. Journal of Nuclear Medicine 52:926-933.
53. Rajon DA, Jokisch DW, Patton PW, Shah AP, Bolch WE. 2000. Voxel size efects in three-dimensional nuclear magnetic resonance microscopy performed for trabecular bone dosimetry. Medical Physics 27:2624-2635.
54. Roeske JC, Aydogan B, Bardies M, Humm JL. 2008. Small-scale dosim-etry: Challenges and future directions. Seminars in Nuclear Medicine 38:367-383. (Pubitemid 352033560)
55. Sastry KSR, Haydock C, Basha AM, Rao DV. 1985. Electron dosimetry for radioimmunotherapy: Optimal electron energy. Radiation Protection Dosimetry 13:249-252. (Pubitemid 16153923)
56. 124I PET and 3-dimensional-internal dosimetry (3D-ID) software. Journal of Nuclear Medicine 45:1366-1372. (Pubitemid 47618537)
57. Sgouros G, Roeske JC, McDevitt MR, Palm S, Allen BJ, Fisher DR, Brill AB, Song H, Howell RW, Akabani G, et al. 2010. MIRD Pamphlet No. 22 (abridged): Radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy. Journal of Nuclear Medicine 51:311-328.
58. Snyder WS, Ford MR, Warner GG, Watson SB. 1975. 'S' absorbed dose per unit cumulated activity for selected radionuclides and organs. New York: Society of Nuclear Medicine.
59. Spaic R, Ilic R, Dragovic M, Petrovic B. 2005. Generation of dose-volume histograms using Monte Carlo simulations on a multicellular model in radionuclide therapy. Cancer Biotherapy and Radiophar-maceuticals 20:320-324. (Pubitemid 41003836)
60. Stabin MG. 2003. Developments in the internal dosimetry of radiop-harmaceuticals. Radiation Protection Dosimetry 105:575-580.
61. Uusijarvi H, Bernhardt P, Forssell-Aronsson E. 2008. Tumour control probability (TCP) for non-uniform activity distribution in radionuclide therapy. Physics in Medicine and Biology 53: 4369-4381.
62. Wessels BW, Grifth MH. 1986. Miniature thermoluminescent dosimeter absorbed dose measurements in tumor phantom models. Journal of Nuclear Medicine 27:1308-1314. (Pubitemid 17030127)